The long term goal of the present study is to gain further insight into the observation that anti-immunoglobulin (anti-Ig) inhibits mitogen induced proliferation of certain human malignant B cell clones. An in vitro proliferative assay will be developed to characterize the effects of anti-Ig on human B cell malignancies. This assay will be used to identify clonal models for anti-Ig induced inhibition of malignant cell growth. These clonal models will be used to analyze the intracellular signals and biochemical events associated with the inhibitory effect of anti-Ig. These goals will be accomplished as follows. 1). Factors that may influence mitogen induced proliferation, and the ability of anti-Ig to inhibit mitogen induced proliferation, of human malignant lymphocytes will be evaluated. The need for T lymphocytes and monocytes, and serum factors, will be addressed. The nature of the anti-Ig-sIg interaction will be probed by comparing different anti-Ig reagents of different specificities. 2). Malignant lymphocytes from additional patients will be characterized, and the frequency of defined functional types among various morphological and phenotypic subsets of B lymphocyte malignancies will be determined. The assumption that information provided by in vitro assay cannot be duplicated by analysis of morphology or cell surface phenotype will be tested. 3). Human malignant B cell clones will be characterized with respect to actin binding proteins, actin, and calmodulin binding proteins. Comparisons will be made between human malignant B cell clones that respond to anti-Ig and cytochalasin in different ways. Static differences, and dynamic changes, in actin binding proteins and calmodulin binding proteins will be studied by polyacrylamide gel electrophoresis, supported in some cases by column chromatography. New protein synthesis and protein phosphorylation will be determined. The state of actin in the cell will be studied by inhibition of DNAase. Further understanding of the mechanisms by which anti-Ig inhibits human malignant B cell proliferation in vitro may reflect upon mechanisms of normal immunoregulation and has the potential for devising means to predict and enhance the beneficial effects of anti-Ig treatment in clinical situations.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA040424-02
Application #
3180336
Study Section
Immunobiology Study Section (IMB)
Project Start
1986-09-01
Project End
1990-02-28
Budget Start
1988-03-01
Budget End
1989-02-28
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
Boston University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02118
Murphy, T P; Kolber, D L; Rothstein, T L (1990) Elevated expression of Pgp-1 (Ly-24) by murine peritoneal B lymphocytes. Eur J Immunol 20:1137-42
Buckler, A J; Rothstein, T L; Sonenshein, G E (1990) Transcriptional control of c-myc gene expression during stimulation of murine B lymphocytes. J Immunol 145:732-6
Wolfowicz, C B; Lyons, S; Mahon, C A et al. (1989) Isolation of self-recognizing IgG2a monoclonal rheumatoid factors. Clin Immunol Immunopathol 52:313-22
van Haelst-Pisani, C; Cragoe Jr, E J; Rothstein, T L (1989) Cytoplasmic alkalinization produced by the combination of anti-immunoglobulin antibody plus cytochalasin D in murine B lymphocytes. Exp Cell Res 183:251-6
Rothstein, T L (1989) Interleukin-4 enhances peritoneal B cell stimulation induced by phorbol ester. Cell Immunol 120:450-9
Cohen, D P; Rothstein, T L (1989) Adenosine 3',5'-cyclic monophosphate modulates the mitogenic responses of murine B lymphocytes. Cell Immunol 121:113-24
Rothstein, T L; Kolber, D L (1988) Anti-Ig antibody inhibits the phorbol ester-induced stimulation of peritoneal B cells. J Immunol 141:4089-93
van Haelst, C; Rothstein, T L (1988) Cytochalasin stimulates phosphoinositide metabolism in murine B lymphocytes. J Immunol 140:1256-8
Rothstein, T L; Kolber, D L (1988) Peritoneal B cells respond to phorbol esters in the absence of co-mitogen. J Immunol 140:2880-5
Buckler, A J; Kessler, D J; Duyao, M P et al. (1988) Regulation of c-myc gene transcription in B lymphocytes: mechanisms of negative and positive control. Curr Top Microbiol Immunol 141:238-46

Showing the most recent 10 out of 12 publications